DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PROGRAMMED CELL DEATH 1 LIGAND 1
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Lymphoma, Follicular; Melanoma; Carcinoma, Basal Cell; Multiple Myeloma
Unknown
PROGRAMMED CELL DEATH 1 LIGAND 1
×
Maximum Phase:
2
First Approval:
None
UNII:
L4766ELH5T
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-(-)-GOSSYPOL ACETIC ACID
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
R-(-)-GOSSYPOL ACETIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZYH7
2
Small molecule
Investigational
Unknown
Unknown
Hypertriglyceridemia; Lipid Metabolism Disorders
Peroxisome proliferator-activated receptor alpha agonist
ZYH7
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DALANTERCEPT
2
Protein
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Multiple Myeloma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms
Bone morphogenetic protein 10 inhibitor
DALANTERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
EGC16R10V0
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-0873
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis; Arthritis, Rheumatoid; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
MK-0873
×
Maximum Phase:
2
First Approval:
None
UNII:
K4KAC9XCCO
Molecule Type:
Small molecule
Molecular Formula:
C25H18N4O3
Molecular Weight:
422.44
AlogP:
2.31
PSA:
90.93
HBD:
1.0
HBA:
#RotB:
3.0
Source:
[18F]DPA-714
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
[18F]DPA-714
×
Maximum Phase:
2
First Approval:
None
UNII:
0VMV8Z3972
Molecule Type:
Small molecule
Molecular Formula:
C22H27FN4O2
Molecular Weight:
397.48
AlogP:
3.77
PSA:
59.73
HBD:
0.0
HBA:
#RotB:
8.0
Source:
INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN
2
Enzyme
Investigational
Unknown
Unknown
Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell
Unknown
INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN
×
Maximum Phase:
2
First Approval:
None
UNII:
S8GQZ8LF0D
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEROTOCIN
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MEROTOCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GINSENG
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GINSENG
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TILAVONEMAB
2
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease; Supranuclear Palsy, Progressive
Microtubule-associated protein tau inhibitor
TILAVONEMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
MY9Z7GDJ8J
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEDATIOXETINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Alpha-1a adrenergic receptor antagonist
TEDATIOXETINE
×
Maximum Phase:
2
First Approval:
None
UNII:
5H681S8O3S
Molecule Type:
Small molecule
Molecular Formula:
C18H21NS
Molecular Weight:
283.44
AlogP:
4.61
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RECAP
2
Unknown
Investigational
Unknown
Unknown
Acute Kidney Injury
Unknown
RECAP
×
Maximum Phase:
2
First Approval:
None
UNII:
9N4Y2R43OM
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-522
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-522
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOLUENE
2
Small molecule
Investigational
Unknown
Unknown
Hot Flashes
Unknown
TOLUENE
×
Maximum Phase:
2
First Approval:
None
UNII:
3FPU23BG52
Molecule Type:
Small molecule
Molecular Formula:
C7H8
Molecular Weight:
92.14
AlogP:
2.0
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
EPB-348
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPB-348
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VALZIFLOCEPT
2
Protein
Investigational
Unknown
Unknown
Glomerulonephritis, IGA
Unknown
VALZIFLOCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
EA2075XV4Y
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LESOGABERAN
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
GABA-B receptor 1 agonist
LESOGABERAN
×
Maximum Phase:
2
First Approval:
None
UNII:
4D6Q6HGC7Z
Molecule Type:
Small molecule
Molecular Formula:
C3H9FNO2P
Molecular Weight:
141.08
AlogP:
-0.25
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
RONACALERET
2
Small molecule
Investigational
Unknown
Unknown
Fractures, Bone; Osteoporosis
Calcium sensing receptor antagonist
RONACALERET
×
Maximum Phase:
2
First Approval:
None
UNII:
DIH95YP7J3
Molecule Type:
Small molecule
Molecular Formula:
C25H31F2NO4
Molecular Weight:
447.52
AlogP:
3.9
PSA:
78.79
HBD:
3.0
HBA:
#RotB:
11.0
Source:
OMS405
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
OMS405
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BQ-123
2
Protein
Investigational
Unknown
Unknown
Heart Failure; Cardiovascular Diseases; Coronary Disease; Hypertension, Pulmonary; Reperfusion Injury; ST Elevation Myocardial Infarction
Unknown
BQ-123
×
Maximum Phase:
2
First Approval:
None
UNII:
S2A8YZM151
Molecule Type:
Protein
Molecular Formula:
C31H42N6O7
Molecular Weight:
610.71
AlogP:
0.83
PSA:
189.8
HBD:
6.0
HBA:
#RotB:
7.0
Source:
ECHINACEA ANGUSTIFOLIA
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ECHINACEA ANGUSTIFOLIA
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DANUSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase Aurora inhibitor
DANUSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
M3X659D0FY
Molecule Type:
Small molecule
Molecular Formula:
C26H30N6O3
Molecular Weight:
474.57
AlogP:
2.64
PSA:
93.8
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LAPULEUCEL-T
2
Cell
Investigational
Unknown
Unknown
Urinary Bladder Neoplasms
Unknown
LAPULEUCEL-T
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPETIRIMOD ESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPETIRIMOD ESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H92K6N217F
Molecule Type:
Small molecule
Molecular Formula:
C15H23N5O4S
Molecular Weight:
369.45
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BMS-770767
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus; Lipid Metabolism Disorders
Unknown
BMS-770767
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOFILTIC ACID I 123
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Unknown
IODOFILTIC ACID I 123
×
Maximum Phase:
2
First Approval:
None
UNII:
0J7USQ749M
Molecule Type:
Small molecule
Molecular Formula:
C22H35IO2
Molecular Weight:
454.43
AlogP:
7.24
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
NAPTUMOMAB ESTAFENATOX
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell
Trophoblast glycoprotein other
NAPTUMOMAB ESTAFENATOX
×
Maximum Phase:
2
First Approval:
None
UNII:
93T929W6LC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PARATHYROID HORMONE RELATED PROTEIN (1-36)
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PARATHYROID HORMONE RELATED PROTEIN (1-36)
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFIMETORAN
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
Unknown
AFIMETORAN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H32N6O
Molecular Weight:
444.58
AlogP:
4.28
PSA:
92.31
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FASORACETAM
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
FASORACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
42O8UF5CJB
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O2
Molecular Weight:
196.25
AlogP:
0.28
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ORVEPITANT MALEATE
2
Small molecule
Investigational
Unknown
Unknown
Cough
Unknown
ORVEPITANT MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HAX0H28B6W
Molecule Type:
Small molecule
Molecular Formula:
C35H39F7N4O6
Molecular Weight:
744.71
AlogP:
6.8
PSA:
47.1
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ENVAFOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Biliary Tract Neoplasms; Breast Neoplasms; Hepatitis B, Chronic; Neoplasms
Programmed cell death 1 ligand 1 binding agent
ENVAFOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
ES1M06M6QH
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BXT-51072
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BXT-51072
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STRONTIUM MALONATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
STRONTIUM MALONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HM781-36B
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HM781-36B
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
149
150
151
152
153
154
155
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA